Literature DB >> 34283371

Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target.

Ehsan Nourbakhsh1, Ali Mohammadi2, Mohammad Salemizadeh Parizi3, Atena Mansouri4, Farnoosh Ebrahimzadeh5.   

Abstract

Myeloid suppressor cells (MDSCs) are an important class of immune-regulating cells that can suppress T cell function. Most of our knowledge about the function of MDSC comes from studies of cancer models. Recent studies, however, have greatly contributed to the description of MDSC involvement in autoimmune diseases. They are known as a cell population that may negatively affect immune responses by regulating the function of CD4+ and CD8+ cells, which makes them an attractive target for autoimmune diseases therapy. However, many questions about MDSC activation, differentiation, and inhibitory functions remain unanswered. In this study, we have summarized the role of MDSCs in various autoimmune diseases, and the potential of targeting them for therapeutic benefits has been discussed.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Autoimmunity; Diabetes; MDSC; Rheumatoid arthritis; multiple sclerosis

Mesh:

Year:  2021        PMID: 34283371     DOI: 10.1007/s10787-021-00846-3

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  62 in total

Review 1.  Myeloid derived suppressor cells and autoimmunity.

Authors:  Peter Boros; Jordi Ochando; Margit Zeher
Journal:  Hum Immunol       Date:  2016-05-27       Impact factor: 2.850

Review 2.  Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies.

Authors:  Bani Ahluwalia; Luiza Moraes; Maria K Magnusson; Lena Öhman
Journal:  Scand J Gastroenterol       Date:  2018-03-09       Impact factor: 2.423

3.  Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice.

Authors:  Hong-Shiue Chou; Ching-Chuan Hsieh; Horng-Ren Yang; Lianfu Wang; Yusuke Arakawa; Kathleen Brown; Qingyu Wu; Feng Lin; Marion Peters; John J Fung; Lina Lu; Shiguang Qian
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

4.  Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

Authors:  Thomas Condamine; George A Dominguez; Je-In Youn; Andrew V Kossenkov; Sridevi Mony; Kevin Alicea-Torres; Evgenii Tcyganov; Ayumi Hashimoto; Yulia Nefedova; Cindy Lin; Simona Partlova; Alfred Garfall; Dan T Vogl; Xiaowei Xu; Stella C Knight; George Malietzis; Gui Han Lee; Evgeniy Eruslanov; Steven M Albelda; Xianwei Wang; Jawahar L Mehta; Meenakshi Bewtra; Anil Rustgi; Neil Hockstein; Robert Witt; Gregory Masters; Brian Nam; Denis Smirnov; Manuel A Sepulveda; Dmitry I Gabrilovich
Journal:  Sci Immunol       Date:  2016-08-05

5.  Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells.

Authors:  Hong-Shiue Chou; Ching-Chuan Hsieh; Ronald Charles; Lianfu Wang; Timothy Wagner; John J Fung; Shiguang Qian; Lina L Lu
Journal:  Transplantation       Date:  2012-02-15       Impact factor: 4.939

6.  Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.

Authors:  S C Buessow; R D Paul; D M Lopez
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

Review 7.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards.

Authors:  Vincenzo Bronte; Sven Brandau; Shu-Hsia Chen; Mario P Colombo; Alan B Frey; Tim F Greten; Susanna Mandruzzato; Peter J Murray; Augusto Ochoa; Suzanne Ostrand-Rosenberg; Paulo C Rodriguez; Antonio Sica; Viktor Umansky; Robert H Vonderheide; Dmitry I Gabrilovich
Journal:  Nat Commun       Date:  2016-07-06       Impact factor: 14.919

8.  Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model.

Authors:  Daniela Carlos; Frederico R C Costa; Camila A Pereira; Fernanda A Rocha; Juliana N U Yaochite; Gabriela G Oliveira; Fernando S Carneiro; Rita C Tostes; Simone G Ramos; Dario S Zamboni; Niels O S Camara; Bernhard Ryffel; João S Silva
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

Review 9.  Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era.

Authors:  Ammira Al-Shabeeb Akil; Esraa Yassin; Aljazi Al-Maraghi; Elbay Aliyev; Khulod Al-Malki; Khalid A Fakhro
Journal:  J Transl Med       Date:  2021-04-01       Impact factor: 5.531

Review 10.  Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates.

Authors:  Luca Cassetta; Espen S Baekkevold; Sven Brandau; Anna Bujko; Marco A Cassatella; Anca Dorhoi; Carsten Krieg; Ang Lin; Karin Loré; Olivia Marini; Jeffrey W Pollard; Mikael Roussel; Patrizia Scapini; Viktor Umansky; Gosse J Adema
Journal:  Cancer Immunol Immunother       Date:  2019-01-25       Impact factor: 6.968

View more
  1 in total

1.  Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs.

Authors:  Genhong Yao; Jingjing Qi; Xiaojing Li; Xiaojun Tang; Wenchao Li; Weiwei Chen; Nan Xia; Shiying Wang; Lingyun Sun
Journal:  Stem Cell Res Ther       Date:  2022-07-18       Impact factor: 8.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.